Update from the 4th Edition of the World Health Organization of Head and Neck Tumours: Tumours of the Oral Cavity and Mobile Tongue
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tumours of the oral cavity and mobile tongue. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors, WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Sloan P, Gale N, Hunter K, et al. Malignant surface epithelial tumours: Squamous cell carcinoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press, 2017.
Dahlgren L, Dahlstrand HM, Lindquist D, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004;112:1015–9.
Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235–42.
Lingen MW, Xiao W, Schmitt A, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013;49:1–8.
Sgaramella N, Coates PJ, Strindlund K, et al. Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1. Br J Cancer. 2015;113:321–6.
Zafereo ME, Xu L, Dahlstrom KR, Viamonte CA, et al. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol. 2016;56:47–53.
Reuschenbach M, Kansy K, Garbe K, et al. Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany. Oral Oncol. 2013;49(9):937–42.
Bagnardi V, Rota M, Botteri E, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112:580–93.
Goldstein BY, Chang SC, Hashibe M, et al. Alcohol consumption and cancers of the oral cavity and pharynx from 1988 to 2009: an update. Eur J Cancer Prev. 2010;19:431–65.
IARC. (2010). Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum. 96:1–1428.
Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people–a comprehensive literature review. Oral Oncol. 2001;37:401–18.
Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer. 2005;103:1843–9.
Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon: IARC. 2012. http://www.globocan.iarc.fr . Accessed 3 Mar 2016.
Fritsch VA, Gerry DR, Lentsch EJ. Basaloid squamous cell carcinoma of the oral cavity: an analysis of 92 cases. Laryngoscope. 2014;124:1573–8.
Bice TC, Tran V, Merkley MA, et al. Disease-Specific survival with spindle cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2015;153:973–80.
Kass JI, Lee SC, Abberbock S, et al. Adenosquamous carcinoma of the head and neck: Molecular analysis using CRTC-MAML FISH and survival comparison with paired conventional squamous cell carcinoma. Laryngoscope. 2015;125:E371–E6.
Sun Y, Kuyama K, Burkhardt A, Yamamoto H. Clinicopathological evaluation of carcinoma cuniculatum: a variant of oral squamous cell carcinoma. J Oral Pathol Med. 2012;41:303–8.
Mallick S, Breta M, Gupta SD, et al. Angiogenesis, proliferative activity and DNA ploidy in oral verrucous carcinoma: a comparative study including verrucous hyperplasia and squamous cell carcinoma. Pathol Oncol Res. 2015;21:1249–57.
Samman M, Wood HM, Conway C, et al. A novel genomic signature reclassifies an oral cancer subtype. Int J Cancer. 2015;137:2364–73.
Garcia C, Crowson AN. Acantholytic squamous cell carcinoma: is it really a more aggressive tumor? Dermatol Surg. 2011;37:353–6.
Rytkönen AE, Hirvikoski PP, Salo TA. Lymphoepithelial carcinoma: two case reports and a systematic review of oral and sinonasal cases. Head Neck Pathol. 2011;5:327–34.
Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29:167–78.
Li Y, Bai S, Carroll W, Dayan D, et al. Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol. 2013;7:211–23.
Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006;42:229–39.
Woolgar JA, Triantafyllou A. Squamous cell carcinoma and precursor lesions: clinical pathology. Periodontol 2000. 2011;57:51–72.
Almangush A, Bello IO, Coletta RD, et al. For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch. 2015;467:39–46.
Ridge JA, Lydiatt WM, Patel SG, et al. Head and Neck In: Amin MB, Edge S, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2017:79–94.
Reibel J, Gale N, Hille J, et al. Oral potentially malignant disorders and oral epithelial dysplasia. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors, WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Kuribayashi Y, Tsushima F, Morita K, et al. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol. 2015;51:1020–5.
Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770–80.
Gale N, Blagus R, El-Mofty SK, et al. Evaluation of a new grading system for laryngeal squamous intraepithelial lesions—a proposed unified classification. Histopathology. 2014;65:456–64.
Woo SB, Cashman EC, Lerman MA. Human papillomavirus-associated oral intraepithelial neoplasia. Mod Pathol. 2013;26:1288–97.
Vigneswaran N, Carlos R, Lippman S, et al. Multifocal epithelial hyperplasia. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, edotors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Carlos R, Sedano HO. Multifocal papilloma virus epithelial hyperplasia. Oral Surg Oral Med Oral Pathol. 1994;77:631–5.
King MD, Reznik DA, O’Daniels CM, et al. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis. 2002;34:641–8.
Said AK, Leao JC, Fedele S, Porter SR. Focal epithelial hyperplasia—an update. J Oral Pathol Med. 2013;42:435–42.
Archard HO, Heck JW, Stanley HR. Focal epithelial hyperplasia: an unusual oral mucosal lesion found in Indian children. Oral Surg Oral Med Oral Pathol. 1965;20:201–12.
Henke RP, Guèrin-Reverchon I, Milde-Langosch K, et al. In situ detection of human papillomavirus types 13 and 32 in focal epithelial hyperplasia of the oral mucosa. J Oral Pathol Med. 1989;18:419–21.
Bishop J, Gnepp DR, Ro JY. Ectomesenchymal chondromyxoid tumour. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Aldojain A, Jaradat J, Summersgill K, Bilodeau EA. Ectomesenchymal chondromyxoid tumor: a series of seven cases and review of the literature. Head Neck Pathol. 2015;9:315–22.
Nigam S, Dhingra KK, Gulati A. Ectomesenchymal chondromyxoid tumor of the hard palate–a case report. J Oral Pathol Med. 2006;35:126–8.
Goveas N, Ethunandan M, Cowlishaw D, Flood TR. Ectomesenchymal chondromyxoid tumour of the tongue: unlikely to originate from myoepithelial cells. Oral Oncol. 2006;42:1026–8.
Smith BC, Ellis GL, Meis-Kindblom JM, Williams SB. Ectomesenchymal chondromyxoid tumor of the anterior tongue. Nineteen cases of a new clinicopathologic entity. Am J Surg Pathol. 1995;19:519–30.
Bullerdiek J, Ro JY. Thompson LDR. rhabdomyoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Hettmer S, Teot LA, van Hummelen P, et al. Mutations in Hedgehog pathway genes in fetal rhabdomyomas. J Pathol. 2013;231:44–52.
Bullerdiek J, Flucke U. Lymphangioma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Kardon DE, Wenig BM, Heffner DK, Thompson LD. Tonsillar lymphangiomatous polyps: a clinicopathologic series of 26 cases. Mod Pathol. 2000;13:1128–33.
Bruder E, Alaggio R, Kozakewich HP, et al. Vascular and perivascular lesions of skin and soft tissues in children and adolescents. Pediatr Dev Pathol. 2012;15:26–61.
Rekhi B, Sethi S, Kulkarni SS, Jambhekar NA. Kaposiform hemangioendothelioma in tonsil of a child associated with cervical lymphangioma: a rare case report. World J Surg Oncol. 2011;9:57.
Lindhurst MJ, Sapp JC, Teer JK, et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med. 2011;365:611–9.
Bullerdiek J, Flucke U. Haemangioma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Açikgöz A, Sakallioglu U, Ozdamar S, Uysal A. Rare benign tumours of oral cavity–capillary haemangioma of palatal mucosa: a case report. Int J Paediatr Dent. 2000;10:161–5.
Bonet-Coloma C, Mínguez-Martínez I, Palma-Carrió C, et al. Clinical characteristics, treatment and outcome of 28 oral haemangiomas in pediatric patients. Med Oral Patol Oral Cir Bucal. 2011;16:e19–e22.
Maaita JK. Oral tumors in child- ren: a review. J Clin Pediatr Dent. 2000;24:133–5.
Sato M, Tanaka N, Sato T, Amagasa T. Oral and maxillofacial tumours in children: a review. Br J Oral Maxillofac Surg. 1997;35:92–5.
Flucke U, Franchi A. Myofibroblastic sarcoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Fisher C. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas. Ultrastruct Pathol. 2003;428:291–305.
Mentzel T, Dry S, Katenkamp D, Fletcher CD. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol. 1998;22:1228–38.
Inagaki H, Bell D, Brandwein-Gensler M. Mucoepidermoid Carcinoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Bell D, Brandwein-Gensler M, Chiosea S. Pleomorphic Adenoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press; 2017.
Feldman AL, Boy S, Ferry JA, et al. CD30-positive T-cell lymphoproliferative disorder. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press, 2017.
Rosenberg A, Biesma DH, Sie-Go DM, Slootweg PJ. Primary extranodal CD30-positive T-cell non-Hodgkins lymphoma of the oral mucosa. Report of two cases. Int J Oral Maxillofac Surg. 1996;25:57–9.
Sciallis AP, Law ME, Inwards DJ, et al. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol. 2012;25:983–92.
Wang W, Cai Y, Sheng W, Lu H, Li X. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:96–104.
Alobeid B, Pan LX, Milligan L, et al. Eosinophil-rich CD30+ lymphoproliferative disorder of the oral mucosa. A form of “traumatic eosinophilic granuloma”. Am J Clin Pathol. 2004;121:43–50.
Hirshberg A, Amariglio N, Akrish S, et al. Traumatic ulcerative granuloma with stromal eosinophilia: a reactive lesion of the oral mucosa. Am J Clin Pathol. 2006;126:522–9.
Boy S, Ferry JA. Plasmablastic lymphoma. In: el-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumours of the head and neck. 4th ed. Lyon: IARC Press, 2017.
Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015;125:2323–30.
Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804–9.
Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413–20.
Boy S, van Heerden M, Pool R, et al. Plasmablastic lymphoma versus diffuse large B-cell lymphoma with plasmablastic differentiation: proposal for a novel diagnostic scoring system. J Hematop. 2015;8:3–11.